NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Novalis LifeSciences

Novalis LifeSciences

Portsmouth, New Hampshirenovalislifesciences.com

Overview

Novalis LifeSciences is a globally acting venture capital firm focused on breakthrough technologies in Life Science . It invests in small to medium size life science companies operating in the biopharma therapeutics, diagnostics, and life science tools sectors . The firm funds and advises visionary Life Science entrepreneurs .

Year Founded

2017

AUM

$500M

Portfolio Companies

21

Investments

Novalis LifeSciences investments
CompanyDateStageLead
FlywheelJan 2026Early FundingLead
Mercy BioAnalyticsSep 2025Series BLead
AnimerraFeb 2025Series CCo-investor
AIRNASep 2023Series ACo-investor
BlueWhale BioSep 2023SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPortsmouth, New Hampshire
Year Founded2017
AUM$500M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.